Pepe v. Cocrystal Pharma, Inc
Pepe v. Cocrystal Pharma, Inc is a federal securities / commodities lawsuit filed on 09/20/2018 in the District Court, D. New Jersey. The case was terminated on 12/16/2020.
A lawsuit records allegations and procedural activity. Being named as a party does not establish liability, wrongdoing, or the merits of any claim.
- Court
- District Court, D. New Jersey (D.N.J.)
Official Court Website → - Assigned judge
- Kevin McNulty · 2,008 cases in index
- Docket number
- 2:18-cv-14091
- Cause
- 15:78m(a) Securities Exchange Act
15 U.S.C. § 78m - Nature of suit
- 850 Securities/Commodities
Alleged violations of federal securities or commodities laws. - Jurisdiction
- Federal Question
- Jury demand
- Plaintiff
- Date filed
- 09/20/2018
- Date terminated
- 12/16/2020
2,781 Securities / Commodities cases in this court are indexed here.
Parties
- plaintiff · Pepe · 89 cases
- defendant · Cocrystal Pharma Inc Pharmaceuticals & Biotechnology · 4 cases
Other Cases Naming This Defendant
Cocrystal Pharma Inc is named in 4 federal civil cases in this index. Recent Securities / Commodities cases naming the same defendant:
About Securities / Commodities Lawsuits
Securities cases involve alleged violations of federal securities or commodities laws — including fraud, misstatements to investors, insider trading, and shareholder class actions brought under the Securities Act and Securities Exchange Act.
Frequently Asked Questions
What is Pepe v. Cocrystal Pharma, Inc?
Pepe v. Cocrystal Pharma, Inc is a federal securities / commodities lawsuit filed on 09/20/2018 in the District Court, D. New Jersey. The case was terminated on 12/16/2020. Securities cases involve alleged violations of federal securities or commodities laws — including fraud, misstatements to investors, insider trading, and shareholder class actions brought under the Securities Act and Securities Exchange Act.
What type of case is this?
It is classified as “Securities / Commodities” under the federal nature-of-suit system. Securities cases involve alleged violations of federal securities or commodities laws — including fraud, misstatements to investors, insider trading, and shareholder class actions brought under the Securities Act and Securities Exchange Act.
What court is the case in?
The case is in the District Court, D. New Jersey, docket number 2:18-cv-14091.
When was the case filed?
Pepe v. Cocrystal Pharma, Inc was filed on 09/20/2018. It was terminated on 12/16/2020.
What law is the case brought under?
The docket lists the cause as 15 U.S.C. § 78m.
Other Cases Involving These Parties
Related Securities / Commodities Cases
Source: public U.S. federal court record — docket 7919951 in the CourtListener/RECAP archive (verify this docket), court docket number 2:18-cv-14091 on PACER. Court, party, date and judge fields are reproduced from that record; case-type categories, statute decoding and all aggregate figures are derived by Docket Nexus (methodology).